Pay in 4 interest-free payments of $23.80 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
(-)-BAY-K-8644
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors
whereas (S)-(−)-BAY-K-8644 impairs rotarod and motor activity
Mdivi-1 is a selective cell-permeable inhibitor of mitochondrial division dynamin-related GTPase (DRP1) and mitochondrial division dynamin I (Dnm1)
Brain Res Dev Brain Res
Gimeracil Size:Solid 2 mg (-)-BAY-K-8644Gimeracil is a pyridine derivative with antitumor activity. Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). Product information CAS Number: 103766 25 2 Molecular Weight: 145. 54 Formula: C5H4ClNO2
US$ 69.96
US$ 1067.00
US$ 1787.00
US$ 4336.50
US$ 924.50
US$ 2136.50
US$ 1007.00